The effect of combination therapy with interferon and cryofiltration on mesangial proliferative glomerulonephritis originating from mixed cryoglobulinemia in chronic hepatitis C virus infection

Therapeutic Apheresis

Volumn 3, Issue 4, 1999, Pages 329-333

  Kiyomoto, Hideyasu ^a   Hitomi, Hirofumi ^a   Hosotani, Youko ^a   Hashimoto, Mayuko ^a   Uchida, Kouichi ^a   Kurokouchi, Kazutaka ^a   Nagai, Masami ^a   Takahashi, Norihiro ^a   Fukunaga, Megumu ^a   Mizushige, Katsufumi ^a   Matsuo, Horohide ^a   Yuasa, Shigekazu ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b Kagawa Prefectural College of Health Sciences   (Japan)

Author keywords

Cryofiltration; Cryoglobulin; Hepatitis C virus; Interferon; Membranoproliferative glomerulonephritis

Indexed keywords

ALPHA INTERFERON; CRYOGLOBULIN; PREDNISOLONE;

AGED; BLEEDING; BONE MARROW SUPPRESSION; CASE REPORT; CONFERENCE PAPER; CRYOFILTRATION; CRYOGLOBULINEMIA; CRYOTHERAPY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY FAILURE; LEG EDEMA; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEINURIA;

AGED; ANTIVIRAL AGENTS; COMBINED MODALITY THERAPY; CRYOGLOBULINEMIA; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMODIAFILTRATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 6544243438     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.1999.00196.x     Document Type: Conference Paper

References (14)

1. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 1998;54: 650-71.
2. Fornasieri A, Armelloni S, Bernasconi P, Li M, Pinerolo De Septis C, Sinico RA, D'Amico G. High binding of immunoglobulin Mκ rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996; 27:476-83.
3. Hoofnagle JH, Di Bisceglie A. The treatment of chronic hepatitis. N Engl J Med 1997;336:347-56.
4. Bonomo L, Casato M, Afeltra A, Caccavo D. Treatment of idiopathic mixed cryoglobulinemia with alpha interferon. Am J Med 1987;83:726-30.
5. Adinolfi LE, Utili R, Zampino R, Ragone E, Mormone G, Ruggiero G. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinemia. Eur J Gastroenterol Hepatol 1997;9:1067-72.
6. Suzuki M, Wakasugi K, Fujitsuka M, Azuma N, Nobuto T, Smith JW, Koo AP, Malchesky PS, Clough JD, Williams GM, Nosé Y. Treatment of rheumatoid arthritis by cryofiltration: A controlled trial. Therapeutic plasmapheresis (VI). Cleveland: ISAO Press, 1986;9:69-77.
7. Brouet J, Clauvel JP, Danon F, Klein M, Seligman M. Biological and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-8.
8. Galli M, Monti G, Monteverde A. Hepatitis C virus and mixed cryoglobulinemias. Lancet 1992;1:989.
9. Pechére-Bertschi A, Perrin L, De Sassure P, Widmann JJ, Giostra E, Schifferli JA. Hepatitis C: A possible etiology for cryoglobulinemia type II. Clin Exp Immunol 1992;89:419-22.
10. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnini S, Gentilini P, Brechot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382.
11. Ferri C, Monti M, La Civita L, Longobardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
12. Gyotoku Y, Abdelmoula M, Spertini F, Izui S, Lambert PH. Cryoglobulinemia induced by monoclonal immunoglobulin G rheumatoid factor derived from autoimmune MRL/MpJ-1pr/ 1pr mice. J Immunol 1987;138:3785-92.
13. Reininger L, Berney T, Shibata T, Spertini F, Merino R, Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: Skin vasculitis and glomerulonephritis arise from distinct pathogenetic mechanisms. Proc Natl Acad Sci USA 1990; 87:10038-42.
14. Haydey RP, Patarroyo De Royas M, Gigli IA. A new described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement). J Invest Dermatol 1980;74:328-33.